Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) will report first quarter 2026 financial results and host a conference call on April 30, 2026 at 5:00 p.m. ET.

Investors can join via live webcast on the company Investors page or register for telephone access; a replay will be posted on the Investors page.

News Market Reaction – EBS

+2.20%

+2.20% Session close to close

In the Apr 17 session, EBS gained 2.20%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timetable for Emergent BioSolutions’ first quarter 2026 results, with a c...

Analysis

This announcement sets the timetable for Emergent BioSolutions’ first quarter 2026 results, with a conference call on April 30, 2026 at 5:00 p.m. ET. The news is logistical, not providing any preliminary financial data. Historically, a similar earnings-date notice led to a modest -1.63% move, suggesting investors may focus more on the forthcoming numbers and commentary than on scheduling details alone.

Key Figures

Earnings call date: April 30, 2026 Earnings call time: 5:00 p.m. ET Quarter reported: First quarter 2026

3 metrics

Earnings call date April 30, 2026 Q1 2026 financial results conference call

Earnings call time 5:00 p.m. ET Start time for Q1 2026 results discussion

Quarter reported First quarter 2026 Period to be discussed on upcoming call

Previous Earnings date Reports

1 past event · Latest: Feb 12 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 12	Earnings call notice	Neutral	-1.6%	Scheduled Q4 and full-year 2025 earnings call with webcast access details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings-date scheduling news saw a modest negative next-day move, suggesting some tendency toward mild weakness around such announcements.

Recent Company History

This announcement continues Emergent BioSolutions’ pattern of formally scheduling earnings calls and providing web access details. A prior earnings date notice on Feb 12, 2026 for Q4 and full-year 2025 results preceded a -1.63% move, indicating the market has historically reacted slightly negatively to such neutral logistics updates rather than treating them as catalysts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

GAITHERSBURG, Md., April 16, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 30, 2026, at 5:00 p.m. eastern time to discuss the financial results for the first quarter of 2026.

Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.

A replay of the call can be accessed from the Investors page of Emergent’s website.

About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.

Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com  

Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com

FAQ

When will Emergent BioSolutions (EBS) report Q1 2026 results and hold the conference call?

The Q1 2026 results and conference call are scheduled for April 30, 2026 at 5:00 p.m. ET. According to the company, the call will cover first quarter 2026 financial results and be available via webcast and telephone registration.

How can investors access the Emergent BioSolutions (EBS) April 30, 2026 conference call?

Investors can access the call via live webcast on the company's Investors page or by telephone after registration. According to the company, telephone participants must register in advance to receive dial-in details and a unique passcode.

What information is provided after registering for the Emergent BioSolutions (EBS) conference call?

Registered telephone participants receive a confirmation email with the dial-in number, unique passcode, and registrant ID. According to the company, the email details how to join the call and use the access credentials.

Will a replay of the Emergent BioSolutions (EBS) April 30, 2026 call be available after the event?

Yes, a replay will be available on the company's Investors page after the live call. According to the company, the replay can be accessed from the Investors page for those who cannot join live.

Do investors need to pre-register to join Emergent BioSolutions (EBS) by phone on April 30, 2026?

Yes, telephone participation requires advance registration to receive the dial-in details and passcode. According to the company, registration is necessary so participants get a confirmation email with joining instructions.

Where can I find the webcast link and investor materials for Emergent BioSolutions (EBS) Q1 2026 results?

The webcast link and related investor materials will be posted on the company's Investors page. According to the company, the Investors page hosts the live webcast, conference details, and the post-call replay.